Tamsulosin Hydrochloride
Product Images NDC 68151-2346

7 FDA label images from Carilion Materials Management · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Tamsulosin Hydrochloride (NDC 68151-2346). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Carilion Materials Management, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label Image (68151 2346)

Label Image (68151 2346)
Label for Tamsulosin Hydrochloride 0.4 mg capsule, manufactured by SUN, with lot number JKM6136A, expiration date 08/14, and barcode 0000002346. Label includes product NDC 68151-2346 and designation RX Only.*
FDA Label Image

Figure-1 (Tamsulosin Fig1)

Figure-1 (Tamsulosin Fig1)
A line graph depicting plasma concentration (ng/mL) of Tamsulosin Hydrochloride over time (hours) up to 36 hours. Two curves compare plasma levels under fasted (dashed line) and fed (solid line) conditions, showing differences in absorption and concentration profiles.*
FDA Label Image

Figure-2a (Tamsulosin Fig2a)

Figure-2a (Tamsulosin Fig2a)
A line graph showing mean change over duration of treatment in weeks for three groups: 0.8 mg dosage, 0.4 mg dosage, and placebo. Mean change is plotted on the vertical axis, decreasing consistently over 13 weeks and last observation carried forward (LOCF) period. The graph includes sample sizes at multiple time points for each group, with 0.8 mg showing the greatest decrease, followed by 0.4 mg, and placebo showing the least change.*
FDA Label Image

Figure-2b (Tamsulosin Fig2b)

Figure-2b (Tamsulosin Fig2b)
A line graph displaying mean change over the duration of treatment in weeks for three treatment groups: 0.8 mg dose, 0.4 mg dose, and placebo. The x-axis represents treatment duration from 0 to 13 weeks plus a last observation carried forward (LOCF) point, with sample sizes indicated below each time point. The y-axis shows mean change values, ranging approximately from 0 to -11. The graph includes distinct symbols for each treatment group and indicates differences in treatment effect over time.*
FDA Label Image

Tamsulosin-fig3a (Tamsulosin Fig3a)

Tamsulosin-fig3a (Tamsulosin Fig3a)
A line graph depicting mean change in mL/sec over treatment duration in weeks for Tamsulosin Hydrochloride doses 0.8 mg and 0.4 mg compared to placebo. The graph includes data points and trends for each treatment arm with sample sizes at each time point. The y-axis shows mean change, and the x-axis shows treatment duration in weeks.*
FDA Label Image

Tamsulosin-fig3b (Tamsulosin Fig3b)

Tamsulosin-fig3b (Tamsulosin Fig3b)
A line graph showing mean change in milliliters per second (mL/sec) over weeks of treatment. The x-axis represents duration of treatment in weeks (0, 1, 2, 5, 9, 13, LOCF), and the y-axis shows mean change up to 3 mL/sec. Three lines illustrate treatment effects: 0.8 mg (circle markers), 0.4 mg (triangle markers), and placebo (square markers). Sample sizes for each time point are indicated.*
FDA Label Image

Chemical-structure (Tamsulosin Str)

Chemical-structure (Tamsulosin Str)
Chemical structure of Tamsulosin Hydrochloride showing its molecular arrangement including aromatic rings, functional groups, and hydrochloride salt form.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.